MedTrace Logo

Fascia Iliaca Blocks for Total Hip Arthroplasty

NCT03691337 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2020-09-10

No results posted yet for this study

Summary

The development of minimal-incision techniques for total hip arthroplasty (THA) with preservation of soft tissue is generally associated with reduction of postoperative pain and increased patient comfort. Although this technique requires a smaller incision than other approaches used for hip surgery, adequate postoperative pain management remains crucial for enhanced recovery and early rehabilitation. The fascia iliaca block (FIB) is commonly used to enhance analgesia after hip replacement surgery, however the effect of FIB volume on analgesia quality and sensory-motor blockade have not been adequately studied. In this study, total postsurgical opioid consumption (morphine equivalents IV in hospital and oral at home) through the first postoperative week will be compared and extent and duration of sensory motor block through the 2-day inpatient stay will be evaluated.

Conditions

  • THA

Interventions

DRUG

Marcaine 0.25 % Injectable Solution

Fascia iliaca block with volume 0.11 mL x subject height

DRUG

Marcaine 0.25 % Injectable Solution

Fascia iliaca block with volume 0.22 mL x subject height

DRUG

Sodium chloride

Fascia iliaca block with volume 0.11 mL x subject height

Sponsors & Collaborators

  • New York School of Regional Anesthesia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-15
Primary Completion
2019-11-12
Completion
2019-12-04

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03691337 on ClinicalTrials.gov